Aptamer-Targeted Gold Nanoparticles As Molecular-Specific Contrast Agents for Reflectance Imaging

Targeted metallic nanoparticles have shown potential as a platform for development of molecular-specific contrast agents. Aptamers have recently been demonstrated as ideal candidates for molecular targeting applications. In this study, we investigated the development of aptamer-based gold nanoparticles as contrast agents, using aptamers as targeting agents and gold nanoparticles as imaging agents. We devised a novel conjugation approach using an extended aptamer design where the extension is complementary to an oligonucleotide sequence attached to the surface of the gold nanoparticles. The chemical and optical properties of the aptamer−gold conjugates were characterized using size measurements and oligonucleotide quantitation assays. We demonstrate this conjugation approach to create a contrast agent designed for detection of prostate-specific membrane antigen (PSMA), obtaining reflectance images of PSMA(+) and PSMA(−) cell lines treated with the anti-PSMA aptamer−gold conjugates. This design strategy can easily be modified to incorporate multifunctional agents as part of a multimodal platform for reflectance imaging applications.

[1]  Kort Travis,et al.  Plasmon resonance coupling of metal nanoparticles for molecular imaging of carcinogenesis in vivo. , 2007, Journal of biomedical optics.

[2]  D. S. Coffey,et al.  Identification and characterization of nuclease-stabilized RNA molecules that bind human prostate cancer cells via the prostate-specific membrane antigen. , 2002, Cancer research.

[3]  Laura A Lavery,et al.  Labeling tumor cells with fluorescent nanocrystal-aptamer bioconjugates. , 2006, Biosensors & bioelectronics.

[4]  Kadir Aslan,et al.  Nanogold-plasmon-resonance-based glucose sensing. , 2004, Analytical biochemistry.

[5]  R. Richards-Kortum,et al.  Oligonucleotide-coated metallic nanoparticles as a flexible platform for molecular imaging agents. , 2007, Bioconjugate chemistry.

[6]  Shi Ke,et al.  Comparison of visible and near-infrared wavelength-excitable fluorescent dyes for molecular imaging of cancer. , 2007, Journal of biomedical optics.

[7]  L. Gold,et al.  Aptamers as therapeutic and diagnostic agents. , 2000, Journal of biotechnology.

[8]  Michele Follen,et al.  Real-time vital optical imaging of precancer using anti-epidermal growth factor receptor antibodies conjugated to gold nanoparticles. , 2003, Cancer research.

[9]  Rebecca Richards-Kortum,et al.  Widefield and high-resolution reflectance imaging of gold and silver nanospheres. , 2007, Journal of biomedical optics.

[10]  Chad A Mirkin,et al.  Maximizing DNA loading on a range of gold nanoparticle sizes. , 2006, Analytical chemistry.

[11]  D. Bunka,et al.  Aptamers come of age – at last , 2006, Nature Reviews Microbiology.

[12]  Joshua E. Smith,et al.  Gold nanoparticle-based colorimetric assay for the direct detection of cancerous cells. , 2008, Analytical chemistry.

[13]  Andrew D Ellington,et al.  Aptamer:toxin conjugates that specifically target prostate tumor cells. , 2006, Cancer research.

[14]  J. Storhoff,et al.  A DNA-based method for rationally assembling nanoparticles into macroscopic materials , 1996, Nature.

[15]  Gang Liu,et al.  Coverage effects and the nature of the metal-sulfur bond in S/Au(111): high-resolution photoemission and density-functional studies. , 2003, Journal of the American Chemical Society.

[16]  Jian Zhang,et al.  Saccharide Sensing Using Gold and Silver Nanoparticles-A Review , 2004, Journal of Fluorescence.